UBS Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-250
| Closed | – | – | 7585 |
|
|
2019
Q4 | $0 | Hold |
250
| – | – | ﹤0.01% | 7397 |
|
|
2019
Q3 | $1K | Buy |
250
+40
| +19% | +$160 | ﹤0.01% | 6951 |
|
|
2019
Q2 | $1K | Hold |
210
| – | – | ﹤0.01% | 6917 |
|
|
2019
Q1 | $1K | Sell |
210
-2,568
| -92% | -$12.2K | ﹤0.01% | 6791 |
|
|
2018
Q4 | $11K | Buy |
2,778
+109
| +4% | +$432 | ﹤0.01% | 6287 |
|
|
2018
Q3 | $53K | Buy |
2,669
+1,830
| +218% | +$36.3K | ﹤0.01% | 5235 |
|
|
2018
Q2 | $27K | Buy |
839
+488
| +139% | +$15.7K | ﹤0.01% | 5574 |
|
|
2018
Q1 | $13K | Sell |
351
-406
| -54% | -$15K | ﹤0.01% | 5856 |
|
|
2017
Q4 | $59K | Buy |
+757
| New | +$59K | ﹤0.01% | 4773 |
|